Skip to content
Regulations & Compliance

GLP compliance

Good Laboratory Practice, a quality system for non-clinical laboratory studies. GLP-compliant studies follow standardized procedures for planning, performing, monitoring, and reporting, ensuring data integrity for regulatory submissions.

Frequently Asked Questions

What is GLP compliance?
Good Laboratory Practice, a quality system for non-clinical laboratory studies. GLP-compliant studies follow standardized procedures for planning, performing, monitoring, and reporting, ensuring data integrity for regulatory submissions.
Why is GLP compliance important in peptide research?
Understanding glp compliance is crucial for navigating the legal and regulatory landscape of peptide use. Regulatory knowledge helps practitioners and patients distinguish between approved therapies, compounded medications, and research chemicals.

Related Terms

Preclinical

The research stage involving in vitro (cell culture) and in vivo (animal) studies before human clinical trials begin. Most peptides outside GLP-1 agonists remain at this evidence stage.

IND (investigational new drug)

An application submitted to the FDA before human clinical trials can begin. The IND includes preclinical data, manufacturing information, and the proposed clinical trial protocol.

ICH guidelines

International Council for Harmonisation guidelines that unify pharmaceutical regulatory requirements across the US, EU, and Japan. Cover drug quality, safety, efficacy, and multidisciplinary topics.

← Back to full glossary